Study Type: Real-World Evidence

Kossack Nils, Schoenfelder T., Schultze Michael, Pignot Marc, Mehta S., Nazareth T., Walzer S., Real-World Cost Difference in Patients With Psoriasis Initiating Apremilast vs. Secukinumab After Conventional Systemic Therapy Using German Sickness Fund Data DDK KOMPAKT 2020. JDDG Volume 18 Issue S1. 2020. 2020; 10.1111/ddg.14021.

Vogelmeier Claus F., Pignot Marc, Wiklund F., Nuevo J., Telg G., Janson C., Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx). European Respiratory Journal. 2020; 10.1183/13993003.

Vogelmeier Claus F., Nuevo J., Telg G., Friedrich Felix W., Pignot Marc, Wiklund F., Janson C., Real-Life Treatment Patterns and Burden of Disease Among Patients with COPD - A Large Observational Study. American Journal of Respiratory and Critical Care Medicine. 2020; 10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A3331.

O'Kelly James, Bartsch Robert, Kossack Nils, Borchert Julia, Pignot Marc, Hadji Peyman, Real-World Effectiveness of Osteoporosis Treatments in Germany Value in Health, Volume 23. 2020; S592. 10.1016/j.jval.2020.08.1134.

Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Haller Hermann, Linssen Gerard C. M., Banerjee Amitava, Thuresson Marcus, Okami Suguru, Garal-Pantaler Elena, Overbeek Jetty, Mamza Jil Billy, Zhang Ruiqi, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes Obes Metab.. 2020; 22:1607–1618. 10.1111/dom.14074.

Hilz M., Das Mahapatra P., Fan Q., Marczykowski F., Werner B., Pignot Marc, Bender J., Punekar R., Hamed A., Edigkaufer M., Evaluation of Treatment Patterns of Fabry Disease Utilizing Medical Claims Analyses of a German Sickness Fund Database Value in Health, VOLUME 23. 2020; SUPPLEMENT 1, S347. 10.1016/j.jval.2020.04.1321.

Kossack Nils, Schoenfelder T., Schultze Michael, Pignot Marc, Mehta S., Nazareth T., Walzer S., Real-World Cost Difference in Patients with Psoriasis Newly Initiating Apremilast vs. Biologic Treatment after Conventional Systemic Therapy: A Retrospective Analysis of German Sickness Fund Data. Value in Health (22). 2019; 10.1016/j.jval.2019.09.2645.

Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Thuresson Marcus, Pignot Marc, Garal-Pantaler Elena, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study EASD Congress. 2019;

Birkeland Kåre I., Bodegard Johan, Eriksson Jan W., Norhammar Anna, Thuresson Marcus, Pignot Marc, Garal-Pantaler Elena, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study European Association for the Study of Diabetes 55th Annual Meeting. 2019;

Birkeland Kåre I., Bodegard Johan, Norhammar Anna, Kuiper JG, Georgiado E., Beekman- Hendriks WL, Thuresson Marcus, Pignot Marc, Herings RMC, Kooy A., How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. Diabetes Obes Metab. 2019; 10.1111/dom.13612.

Kraus MR, Kleine H., Thönnes S., Pignot Marc, Sanchez Gonzalez Y., Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data. Infect Dis Ther.. 2018; 7(3):339-352. 10.1007/s40121-018-0205-2.

Kraus MR, Kleine H., Thönnes S., Pignot Marc, Sanchez Gonzalez Y., Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data. Infect Dis Ther. 2018; Sep;7(3):327-338. 10.1007/s40121-018-0204-3.